8-K
Current Report
Protalix BioTherapeutics, Inc. Filed Acc 0001558370-22-006566
Material agreement
- Item 1.01 Entry into a material definitive agreement
From the SEC's structured data for this filing
Loading plx-20220502x8k.htm…